These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
368 related items for PubMed ID: 16269045
1. Long-term results of basiliximab induction immunosuppression in pediatric liver transplant recipients. Ganschow R, Grabhorn E, Schulz A, Von Hugo A, Rogiers X, Burdelski M. Pediatr Transplant; 2005 Dec; 9(6):741-5. PubMed ID: 16269045 [Abstract] [Full Text] [Related]
10. Improved treatment response with basiliximab immunoprophylaxis after liver transplantation: results from a double-blind randomized placebo-controlled trial. Neuhaus P, Clavien PA, Kittur D, Salizzoni M, Rimola A, Abeywickrama K, Ortmann E, Chodoff L, Hall M, Korn A, Nashan B, CHIC 304 International Liver Study Group. Liver Transpl; 2002 Feb; 8(2):132-42. PubMed ID: 11862589 [Abstract] [Full Text] [Related]
12. Immunoprophylaxis with basiliximab, a chimeric anti-interleukin-2 receptor monoclonal antibody, in combination with azathioprine-containing triple therapy in liver transplant recipients. Calmus Y, Scheele JR, Gonzalez-Pinto I, Jaurrieta EJ, Klar E, Pageaux GP, Scudamore CH, Cuervas-Mons V, Metselaar HJ, Prestele H, Girault D. Liver Transpl; 2002 Feb; 8(2):123-31. PubMed ID: 11862588 [Abstract] [Full Text] [Related]
13. Comparison of single bolus ATG and Basiliximab as induction therapy in presensitized renal allograft recipients receiving tacrolimus-based immunosuppressive regimen. Yang SL, Wang D, Wu WZ, Lin WH, Xu TZ, Cai JQ, Tan JM. Transpl Immunol; 2008 Jan; 18(3):281-5. PubMed ID: 18047938 [Abstract] [Full Text] [Related]
14. The role of anti-IL-2 receptor in high-risk kidney transplant patients. Jirasiritham S, Sumethkul V, Mavichak V, Lertsithichai P, Jirasiritham S. Transplant Proc; 2004 Sep; 36(7):2110-2. PubMed ID: 15518764 [Abstract] [Full Text] [Related]
18. Ten-year follow-up of basiliximab induction therapy for live-donor kidney transplant: a prospective randomized controlled study. Sheashaa HA, Bakr MA, Rashad RH, Ismail AM, Sobh MA, Ghoneim MA. Exp Clin Transplant; 2011 Aug; 9(4):247-51. PubMed ID: 21819369 [Abstract] [Full Text] [Related]
19. Basiliximab: a review of its use as induction therapy in renal transplantation. McKeage K, McCormack PL. BioDrugs; 2010 Feb 01; 24(1):55-76. PubMed ID: 20055533 [Abstract] [Full Text] [Related]
20. Reduction of the occurrence of acute cellular rejection among renal allograft recipients treated with basiliximab, a chimeric anti-interleukin-2-receptor monoclonal antibody. United States Simulect Renal Study Group. Kahan BD, Rajagopalan PR, Hall M. Transplantation; 1999 Jan 27; 67(2):276-84. PubMed ID: 10075594 [Abstract] [Full Text] [Related] Page: [Next] [New Search]